ALDACTAZIDE-INDUCED SODIUM APPETITE IN RATS = APPETIT POUR LE SODIUM INDUIT PAR L'ALDACTAZIDE CHEZ LES RATSWONG R; WILSON CS.1973; BEHAV. BIOL.; U.S.A.; DA. 1973; VOL. 8; NO 2; PP. 285-289; BIBL. 11REF.Article

ESSAI CLINIQUE DU 8109-CB EN CHIRURGIE DIGESTIVEBELANGER JM; ZERBIB J; MARTINEL C et al.1973; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1973; VOL. 9; NO 3; PP. 593-600 (5P.)Serial Issue

3-(16BETA , 17BETA -DIHYDROXY-3-OXOANDROST - 4EN - 17ALPHA - YL) PROPIONIC ACID GAMMA -LACTONE, ITS PREPARATION AND ANTIMINERALOCORTICOID ACTIVITYCHINN LJ; HOFMANN LM.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 7; PP. 839-843; BIBL. 16REF.Article

QUANTITATION OF PLASMA ALDOSTERONE BY RADIOIMMUNOASSAYST CYR MJ; SANCHO JM; MELBY JC et al.1972; CLIN. CHEM.; U.S.A.; DA. 1972; VOL. 18; NO 11; PP. 1395-1402; BIBL. 15 REF.Article

EFFECTS OF ALDOSTERONE ANTAGONISTS ON ORGAN CULTURES OF HUMAN PROSTATIC TISSUE = EFFETS DES ANTAGONISTES DE L'ALDOSTERONE SUR LES CULTURES ORGANIQUES DE TISSUS PROSTATIQUES HUMAINSCASTRO JE; SELLWOOD RA.1974; J. PATHOL.; G.B.; DA. 1974; VOL. 113; NO 4; PP. 217-222; H.T. 1; BIBL. 16REF.Article

EFFECT OF ALDOSTERONE BLOCKADE DURING FASTING AND REFEEDING = EFFET DU BLOCAGE DE L'ALDOSTERONE PENDANT LE JEUNE ET LA REALIMENTATIONBOULTER PR; SPARK RF; ARKY RA et al.1973; AMER. J. CLIN. NUTRIT.; U.S.A.; DA. 1973; VOL. 26; NO 4; PP. 397-402; BIBL. 26 REF.Article

ROLE OF THE ADRENAL CORTEX IN HYPERTENSION = ROLE DU CORTEX SURRENALIEN DANS L'HYPERTENSIONLIDDLE GW; CAREY RM; DOUGLAS JG et al.1973; SOUTH. MED. J.; U.S.A.; DA. 1973; VOL. 66; NO 1; PP. 51-54; BIBL. 27REF.Article

COMPLEX FORMATION BY 3H-ALDOSTERONE IN RAT KIDNEY AND LIVERMORRIS DJ; DAVIS RP.1973; STEROIDS; U.S.A.; DA. 1973; VOL. 21; NO 3; PP. 383-396; BIBL. 15 REF.Article

VARIATIONS DE L'ACTIVITE RENINE ET DE L'ALDOSTERONE DANS UN CAS TYPE SYNDROME DE BARTTER. INFLUENCE DES ANTI-ALDOSTERONES ET DE L'APPORT SODEZECH P; POZET N; SASSARD J et al.1974; J. UROL. NEPHROL.; FR.; DA. 1974; VOL. 80; NO 9; PP. 760-765; BIBL. 13REF.Article

Aldosterone and Mineralocorticoid Receptor Antagonists Modulate Elastin and Collagen Deposition in Human SkinMITTS, Thomas F; BUNDA, Severa; YANTING WANG et al.Journal of investigative dermatology. 2010, Vol 130, Num 10, pp 2396-2406, issn 0022-202X, 11 p.Article

LE RAPPORT SODIUM-POTASSIUM URINAIRE EN REANIMATION A PROPOS DE L'UTILISATION D'UN AGENT ANTIALDOSTERONE (CB8109)ROQUEFEUIL B; VIGUIE E; FOLLEA G et al.1973; ANN. ANESTHESIOL. FR.; FR.; DA. 1973; VOL. 14; NO 3; PP. 281-292; ABS. ANGL. ALLEM. ESP. ITAL. RUSSESerial Issue

Use of Aldosterone Antagonists in Heart FailureALBERT, Nancy M; YANCY, Clyde W; LI LIANG et al.JAMA, the journal of the American Medical Association. 2009, Vol 302, Num 15, pp 1658-1665, issn 0098-7484, 8 p.Article

BEHANDLUNG ESSENTIELLER HYPERTONIKER MIT SPIROLAKTON UNTER BERUECKSICHTIGUNG DER PLASMA-RENIN-AKTIVITAET = TRAITEMENT DE L'HYPERTENSION ARTERIELLE PAR LA SPIRONOLACTONE, AVEC OBSERVATION DE L'ACTIVITE RENINE PLASMATIQUE1973; WIEN. KLIN. WSCHR.; OESTERR.; DA. 1973; VOL. 85; NO 23; PP. 413-417; ABS. ANGL.; BIBL. 5REF.Serial Issue

Use of aldosterone antagonists in resistant hypertensionCALHOUN, David A.Progress in cardiovascular diseases. 2006, Vol 48, Num 6, pp 387-396, issn 0033-0620, 10 p.Article

Aldosterone Antagonists in Patients With Heart Failure. Authors' replyFAYSSOIL, Abdallah; GHALI, Jalal K; ALBERT, Nancy M et al.JAMA, the journal of the American Medical Association. 2010, Vol 303, Num 9, pp 833-835, issn 0098-7484, 3 p.Article

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection FractionHERNANDEZ, Adrian F; XIAOJUAN MI; HAMMILL, Bradley G et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 20, pp 2097-2107, issn 0098-7484, 11 p.Article

Eplerenone Is Not Superior to Older and Less Expensive Aldosterone AntagonistsCHATTERJEE, Saurav; MOELLER, Chaim; SHAH, Nidhi et al.The American journal of medicine. 2012, Vol 125, Num 8, pp 817-825, issn 0002-9343, 9 p.Article

Le médicament du mois Angeliq® : nouvelle hormonothérapie de la ménopause comportant des propriétés antialdostérone et antiandrogéniques = Angeliq®: New hormonal therapy of the menopause, with antialdosterone and antiandrogenic propertiesGASPARD, U; VAN DEN BRULE, F.RMLG. Revue médicale de Liège. 2004, Vol 59, Num 3, pp 162-166, issn 0370-629X, 5 p.Article

Aldosterone receptor antagonists in the medical management of chronic heart failureTANG, W. H; PARAMESWARAN, Anoop C; MAROO, Anjli P et al.Mayo Clinic proceedings. 2005, Vol 80, Num 12, pp 1623-1630, issn 0025-6196, 8 p.Article

A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosisSTEWART, Ralph A. H; KERR, Andrew J; DOUGHTY, Robert N et al.The American heart journal. 2008, Vol 156, Num 2, pp 348-355, issn 0002-8703, 8 p.Article

Anti-aldostérones et insuffisance cardiaque = Antialdosterone and heart failureCASTAIGNE, A.Actualités néphrologiques Jean Hamburger. 2005, pp 191-204, issn 1168-1098, 14 p.Article

Le traitement de l'insuffisance cardiaque du sujet âgé : place des antialdostérones = The treatment of heart failure in the elderly : role of aldosterone antagonistsCHUZEVILLE, Michel.La Revue de gériatrie. 2005, Vol 30, Num 4, pp 259-266, issn 0397-7927, 8 p.Article

A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilationMEENDERING, Jessica R; TORGRIMSON, Britta N; MILLER, Nicole P et al.Contraception (Stoneham). 2010, Vol 82, Num 4, pp 366-372, issn 0010-7824, 7 p.Article

Des recommandations à la pratiqueDIEVART, Francois.Archives des maladies du coeur et des vaisseaux. Pratique. 2006, Num nov, pp 9-11, issn 1261-694X, 3 p., NSConference Paper

Treatment of chronic heart failure : a comparison between the major guidelinesMCMURRAY, John; SWEDBERG, Karl.European heart journal. 2006, Vol 27, Num 15, pp 1773-1777, issn 0195-668X, 5 p.Article